BIOSTAR PHARM-B(02563): Expected audit reservation opinion

13:18 25/03/2026

Huahao Zhongtian Pharmaceuticals-B (02563) issued an announcement, the board of directors of the company hereby notifies the shareholders and potential investors that, during the audit of the comprehensive financial statements for the year ended December 31, 2025, the company's auditor indicated that they are expected to issue a qualified opinion in the audit report.

BIOSTAR PHARM-B (02563) Announces that during the review of the comprehensive financial statements for the year ended December 31, 2025, the company's auditors have indicated that they expect to issue a qualified opinion in their audit report. The company's board of directors hereby informs its shareholders and potential investors of this matter.

Fortune Quick Look at Semiconductor News: Apple Inc. (AAPL.US) C1X achieves "intergenerational leap", NVIDIA Corporation (NVDA.US) new rack priced at a maximum of 8.8 million US dollars.

HK Stock Market Move | YUNJI (02670) rose more than 13% in intraday trading, reaching a new all-time high. Smart body application revenue nearly doubled year-on-year.

Aerospace and defense electronics and parts manufacturer Arxis (ARXS.US) applies for listing or raising $400 million in the US market.

Fortune Quick Look at Semiconductor News: Apple Inc. (AAPL.US) C1X achieves "intergenerational leap", NVIDIA Corporation (NVDA.US) new rack priced at a maximum of 8.8 million US dollars.

HK Stock Market Move | YUNJI (02670) rose more than 13% in intraday trading, reaching a new all-time high. Smart body application revenue nearly doubled year-on-year.

Aerospace and defense electronics and parts manufacturer Arxis (ARXS.US) applies for listing or raising $400 million in the US market.